EEF2K and malignant colon neoplasm: This observation is consistent with our previous finding that EEF2K functioned as a tumor-suppressor gene in CRC by inhibiting autophagic survival and synergized with oxaliplatin (a commonly used chemotherapeutic drug in CRC management) to induce colon cancer cell apoptosis [7].